These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26144293)

  • 1. Endothelin 1 and transforming growth factor-β1 correlate with liver function and portal pressure in cirrhotic patients.
    Wereszczynka-Siemiatkowska U; Swidnicka-Siergiejko A; Siemiatkowski A; Bondyra Z; Wasielica-Berger J; Mroczko B; Janica J; Dabrowski A
    Cytokine; 2015 Dec; 76(2):144-151. PubMed ID: 26144293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The imbalance of peripheral interleukin-18 and transforming growth factor-β1 levels in patients with cirrhosis and esophageal varices.
    Swidnicka-Siergiejko A; Wereszczynska-Siemiatkowska U; Siemiatkowski A; Wasielica-Berger J; Janica J; Mroczko B; Dabrowski A
    Cytokine; 2019 Jan; 113():440-445. PubMed ID: 30392846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TGF beta 1 and ET-1 expression in the peripheral blood of patients with cirrhosis].
    Yang L; Liu X; Fu H; Qiang O; Huang M
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):202-3, 212. PubMed ID: 12600085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
    Luo B; Tang L; Wang Z; Zhang J; Ling Y; Feng W; Sun JZ; Stockard CR; Frost AR; Chen YF; Grizzle WE; Fallon MB
    Gastroenterology; 2005 Aug; 129(2):682-95. PubMed ID: 16083721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
    Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
    Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients.
    Buck M; Garcia-Tsao G; Groszmann RJ; Stalling C; Grace ND; Burroughs AK; Patch D; Matloff DS; Clopton P; Chojkier M
    Hepatology; 2014 Mar; 59(3):1052-9. PubMed ID: 24115225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
    Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
    Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
    Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.
    Lee KC; Yang YY; Wang YW; Lee FY; Loong CC; Hou MC; Lin HC; Lee SD
    Dig Dis Sci; 2010 Jul; 55(7):2077-85. PubMed ID: 19826951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension.
    Kawanaka H; Akahoshi T; Kinjo N; Iguchi T; Ninomiya M; Yamashita YI; Ikegami T; Yoshizumi T; Shirabe K; Maehara Y
    Br J Surg; 2014 Nov; 101(12):1585-93. PubMed ID: 25200126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of portal pressure.
    Abraldes JG; Sarlieve P; Tandon P
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury.
    Bauer S; Eisinger K; Wiest R; Karrasch T; Scherer MN; Farkas S; Aslanidis C; Buechler C
    Regul Pept; 2012 Nov; 179(1-3):10-4. PubMed ID: 22960408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive and noninvasive methods to diagnose portal hypertension and esophageal varices.
    de Franchis R; Dell'Era A
    Clin Liver Dis; 2014 May; 18(2):293-302. PubMed ID: 24679495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.